Dendritic cells: role in skin diseases and therapeutic applications
- 1 May 1999
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 24 (3) , 204-207
- https://doi.org/10.1046/j.1365-2230.1999.00456.x
Abstract
Dendritic cells have entered the centre stage of applied immunological research. Dermatologists knew for quite some time about the extraordinary capacity of these cells to induce immune responses. Recent progress in using these cells as potent adjuvant for the treatment of human cancer has inaugurated an unprecedented wave of publications about the role of these cells for the pathogenesis and treatment of various types of cancers and infectious diseases. This short review attempts to follow some of the origins of dendritic cell research with special regard to dermatology and gives a perspective on newer developments such as the use of dendritic cells to induce antigen-specific tolerance.Keywords
This publication has 16 references indexed in Scilit:
- Vaccination of melanoma patients with peptide- or tumorlysate-pulsed dendritic cellsNature Medicine, 1998
- CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha.The Journal of Experimental Medicine, 1996
- A fresh morphological and functional at dermal dendritic cellsJournal of Cutaneous Pathology, 1995
- From defined human tumor antigens to effective immunization?Immunology Today, 1995
- Dendritic cells as initiators of tumor immune responses: a possible strategy for tumor immunotherapy?Immunology Today, 1995
- Characterization of dermal dendritic cells in psoriasis. Autostimulation of T lymphocytes and induction of Th1 type cytokines.Journal of Clinical Investigation, 1994
- Proliferating dendritic cell progenitors in human blood.The Journal of Experimental Medicine, 1994
- Antigen-presenting capacity in normal human dermis is mainly, subserved by CDla+ cellsBritish Journal of Dermatology, 1994
- Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.The Journal of Experimental Medicine, 1994
- Human and murine dermis contain dendritic cells. Isolation by means of a novel method and phenotypical and functional characterization.Journal of Clinical Investigation, 1993